The molecular mechanisms driving hereditary early-onset CRC have been well defined as germline mutations such as the MLH1, MSH2, MSH6, PMS2, and EPCAM mutations in Lynch syndrome and APC and MUTYH mutations in FAP11, whereas sporadic early-onset CRC has not been fully clarified10. The gene discussed is PMS2; the disease is colorectal carcinoma.